Literature DB >> 11733704

Neural phenotype expression of cultured human cord blood cells in vitro.

Y Ha1, J U Choi, D H Yoon, D S Yeon, J J Lee, H O Kim, Y E Cho.   

Abstract

Neural stem cells have been proposed as useful vectors for treating diseases in the CNS, but their utility is severely limited by lack of accessibility. Brain development is ongoing extensively in early postnatal life. However, it is unclear whether stem cells that differentiate into neurons exist in the blood during early postnatal life. We showed in this experiment that neural markers (NeuN, neurofilament, MAP2, GFAP) are expressed and long cytoplasmic processes are elaborated in the cultured human cord blood monocytes prepared from newborn umbilical blood. These results suggest that stem cells in human cord blood may be potential sources of neurons in early postnatal life. We suggest that the neonatal blood system functions as a circulating pool of different types of stem cell.

Entities:  

Mesh:

Year:  2001        PMID: 11733704     DOI: 10.1097/00001756-200111160-00030

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

Review 1.  Transplantation of umbilical cord blood stem cells for treating spinal cord injury.

Authors:  Dong-Hyuk Park; Jeong-Hyun Lee; Cesario V Borlongan; Paul R Sanberg; Yong-Gu Chung; Tai-Hyoung Cho
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

2.  Do hematopoietic cells exposed to a neurogenic environment mimic properties of endogenous neural precursors?

Authors:  P Walczak; N Chen; J E Hudson; A E Willing; S N Garbuzova-Davis; S Song; P R Sanberg; J Sanchez-Ramos; P C Bickford; T Zigova
Journal:  J Neurosci Res       Date:  2004-04-15       Impact factor: 4.164

Review 3.  The promotion of pediatric neurosurgery throughout the world.

Authors:  Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-09       Impact factor: 1.475

4.  What is the future for cord blood stem cells?

Authors:  E A de Wynter
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

5.  Human umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo.

Authors:  Christopher S Gondi; Krishna Kumar Veeravalli; Bharathi Gorantla; Dzung H Dinh; Dan Fassett; Jeffrey D Klopfenstein; Meena Gujrati; Jasti S Rao
Journal:  Neuro Oncol       Date:  2010-01-22       Impact factor: 12.300

Review 6.  Human umbilical cord blood (HUCB) cells for central nervous system repair.

Authors:  Mary B Newman; Cyndy D Davis; Nicole Kuzmin-Nichols; Paul R Sanberg
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 7.  Systemic delivery of umbilical cord blood cells for stroke therapy: a review.

Authors:  Guolong Yu; Cesar V Borlongan; Christine E Stahl; David C Hess; Yali Ou; Yuji Kaneko; Seong Jin Yu; Tianlun Yang; Li Fang; Xiumei Xie
Journal:  Restor Neurol Neurosci       Date:  2009       Impact factor: 2.406

Review 8.  Human umbilical cord blood stem cells: rational for use as a neuroprotectant in ischemic brain disease.

Authors:  Hadar Arien-Zakay; Shimon Lecht; Arnon Nagler; Philip Lazarovici
Journal:  Int J Mol Sci       Date:  2010-09-21       Impact factor: 5.923

9.  Neuronal conditioning medium and nerve growth factor induce neuronal differentiation of collagen-adherent progenitors derived from human umbilical cord blood.

Authors:  Hadar Arien-Zakay; Arnon Nagler; Hanan Galski; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.